|
||
Original Article |
2 Activation by Regulating B Cell Linker ProteinPLC-
2 Binding
Correspondence to: Tomohiro Kurosaki, Dept. of Molecular Genetics, Institute for Liver Research, Kansai Medical University, Moriguchi 570-8506, Japan. Tel:81-6-6993-9445 Fax:81-6-6994-6099 E-mail:kurosaki{at}mxr.mesh.ne.jp.
Accumulating evidence indicates that the Cbl protein plays a negative role in immune receptor signaling; however, the mode of Cbl action in B cell receptor (BCR) signaling still remains unclear. DT40 B cells deficient in Cbl showed enhanced BCR-mediated phospholipase C (PLC)-
2 activation, thereby leading to increased apoptosis. A possible explanation for the involvement of Cbl in PLC-
2 activation was provided by findings that Cbl interacts via its Src homology 2 (SH2) domain with B cell linker protein (BLNK) after BCR ligation. BLNK is a critical adaptor molecule for PLC-
2 tyrosine phosphorylation through its binding to the PLC-
2 SH2 domains. As a consequence of the interaction between Cbl and BLNK, the BCR-induced recruitment of PLC-
2 to BLNK and the subsequent PLC-
2 tyrosine phosphorylation were inhibited. Thus, our data suggest that Cbl negatively regulates the PLC-
2 pathway by inhibiting the association of PLC-
2 with BLNK.
Key Words: adaptor molecule, antigen receptor, lymphocyte, negative regulator, signaling
This article has been cited by other articles:
| TABLE OF CONTENTS |
|